Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX5GH3
|
||||
| Drug Name |
N-[1-(2S-Ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-4-methanesulfonylamino-3-methoxy-benzamide
|
||||
| Synonyms |
CHEMBL480634
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H35N3O7S
|
||||
| Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)C)c(OC)c3
|
||||
| InChI |
InChI=1S/C24H35N3O7S/c1-5-19-21(18(28)14-34-19)26-23(30)17(13-24(2)10-6-7-11-24)25-22(29)15-8-9-16(20(12-15)33-3)27-35(4,31)32/h8-9,12,17,19,21,27H,5-7,10-11,13-14H2,1-4H3,(H,25,29)(H,26,30)/t17-,19-,21+/m0/s1
|
||||
| InChIKey |
GVXZIDMCXUICPR-HFSMHLIXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.